Download PDF - Foreningen af Kliniske Diætister
Download PDF - Foreningen af Kliniske Diætister
Download PDF - Foreningen af Kliniske Diætister
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
SIDE AK-BEHANDLING – ER DET TIL AT LEVE MED?<br />
14<br />
ARTIKEL<br />
Yderligere information<br />
Der kan hentes yderligere information på<br />
nettet og en <strong>af</strong> vejene kunne f.ex være:<br />
■ www.auh.dk/t - om selvstyret AKbehandling<br />
i AK-centret, Skejby<br />
Sygehus<br />
■ www.sundhed.dk - den direkte vej til<br />
sundhedsvæsenet, hvor man kan blive<br />
guidet videre til relevante sider om AKbehandling.<br />
mmi@sks.aaa.dk ■<br />
Marianne Maegaard<br />
■ Sygeplejerske, færdiguddannet i<br />
1979 i København<br />
■ De seneste 6 år beskæftiget<br />
med AK-behandling<br />
■ Oplæring <strong>af</strong> patienter til selv at<br />
foretage blodprøvetagning og<br />
medicinjustering jf. konceptet:<br />
Selvstyret AK-behandling (introduceret<br />
i DK i 1995)<br />
■ Varetagelse <strong>af</strong> AK-behandling<br />
for børn (Skejby Sygehus, <strong>af</strong>d.<br />
A3)<br />
■ Varetagelse <strong>af</strong> AK-behandling<br />
for voksne patienter (Skejby<br />
Sygehus, <strong>af</strong>d. T)<br />
Litteratur:<br />
1. Levine MN, Raskob G, Landefeld S,<br />
Kearon C. Hemorrhagic complications<br />
of anticoagulant treatment. Chest<br />
2001; 119: 108S-121S.<br />
2. Lauenbjerg J, Egeblad H, He<strong>af</strong> J,<br />
Nielsen NH, Fugleholm AM,<br />
Ladefoged K. Bleeding complications<br />
to oral anticoagulant therapy; multivariate<br />
analysis of 1010 treatment years<br />
in 551 patients. J Intern Med 1991;<br />
229: 351-355.<br />
3. Steffensen FH, Kristensen K, Ejlersen<br />
E, Dahlerup JF, Sørensen HT. Major<br />
haemorhagic complications during<br />
oral anticoagulant therapy in a Danish<br />
population-based cohort. J Intern Med<br />
1997; 242: 497-503.<br />
4. Kaeron C, Hirsh J. Management of<br />
anticoagulation before and <strong>af</strong>ter surgery.<br />
N Engl J Med 1997; 336: 1506-1511.<br />
5. The stroke prevention in Atrial<br />
Fibrillation Investigators. Predictors<br />
of thromboembolism in atrial fibrillation.<br />
I. Clinical features of patients at<br />
risk. Ann Intern Med 1992; 116: 1-5.<br />
6. Risk factors for stroke and efficacy of<br />
antithrombotic therapy in atrial fibrillation:<br />
analysis of pooled data from<br />
five randomised trials. Arch Intern<br />
Med 1994; 154: 1449-1457.<br />
7. Jørgensen T, Danneskjold-Samsøe B,<br />
Godtfredsen J, Jespersen J. På vegne<br />
<strong>af</strong> NEMT og Nordkems projektgruppe:<br />
Antikoagulationsbehandling i<br />
Norden – sammenfattende rapport.<br />
(DSI rapport 94.12) København.<br />
Dansk Sygehus Institut. 1994.<br />
8. Lassen JF: Peroral antikoagulationsbehandling<br />
– en kvalitetsudvikling. Ph.d.<strong>af</strong>handling.<br />
Odense Universitet. 1996.<br />
9. Van der Meer FJ, Rosendaal FR,<br />
Vandenbroucke JP, Briet E.<br />
Assesment of a bleeding risk index in<br />
two cohorts of patients treated with<br />
oral anticoagulants. Thromb Haemost<br />
1996; 76: 12-16.<br />
10. Palereti G, Leali N, Coccheri S, Poggi<br />
M, Manotti C, D´Angelo A. Bleeding<br />
complications of oral anticoagulant<br />
treatment: an inception-cohort, prospective<br />
collaborative study. Lancet<br />
1996; 348: 423-428.<br />
11. Hasenkam JM, Kimose HK, Knudsen<br />
L, Grønnesby H, Halborg J,<br />
Christensen TD, Attermann J,<br />
Pilegaard HK. Selfmanagement of<br />
Oral anticoagulant Therapy <strong>af</strong>ter<br />
Heart Valve Replacement. Eur Cardiothoracic<br />
Surg 1997; 11:935-942.<br />
12. Christensen TC, Attermann J,<br />
Pilegaard HK, Andersen NT,<br />
Maegaard M, Hasenkam JM. Self<br />
management of oral anticoagulant therapy<br />
in children with congenital heart<br />
disease. Cardiology in the Young<br />
2001; 11: 269-276.<br />
13. Köertke H, Körfer R. INR-self management<br />
following medical heart valve<br />
replacement. Is an early start advantageous?<br />
Ann Thorac Surg 2001; 72: 44-48.<br />
14. Gullov AL, Koefoed BG, Petersen P.<br />
Bleeding during Warfarin and Aspirin<br />
therapy in patients with atrial fibrillation:<br />
the AFASAK 2 study. Atrial fibrillation<br />
Aspirin and anticoagulation. Arch<br />
Intern Med 1999; 159:1322-1328.<br />
15. The Stroke Prevention in Atrial<br />
Fibrillation Investigators (SPAF).<br />
Ajusted-dose Warfarin versus low<br />
intensity fixed-dose Warfarin plus<br />
Aspirin for high-risk Patients with<br />
atrial fibrillation: A randomised clinical<br />
trial. Lancet 1996; 348:633-638.<br />
16. Lassen JF, Brandslund I, Antonsen S.<br />
International Normalized Ratio for<br />
Prothrombin Times in Patients Oral<br />
Anticoagulans: Critical Difference and<br />
Probability of Significant Change in<br />
Consecutive Measurements.<br />
Clin Chem 1995; 41: 444-447.<br />
Supplerende litteratur:<br />
Godtfredsen J, Hansen MS, Husted SE,<br />
Jespersen J. En arbejdsgruppe under<br />
Dansk Cardiologisk Selskab og Dansk<br />
Selskab for Klinisk Kemi: Antitrombotisk<br />
behandling ved kardiovaskulære sygdomme.<br />
Klaringsrapport. Ugeskr for Læger.<br />
1997; suppl.5.<br />
Husted SE, Lassen JF, Kræmmer Nielsen<br />
H, Winther Hansen KF Antonsen S,<br />
Dalsgaard Nielsen J, Jespersen J. En<br />
arbejdsgruppe under Dansk Selskab for<br />
Trombose og Hæmostase. Praktiske<br />
aspekter ved peroral antikoagulationsbehandling.<br />
Klaringsrapport. Ugeskr for<br />
Læger. 2001; suppl.13<br />
DIÆTISTEN NR. 72 - 2004